Tulathromycin Patent Expiration
About Veterinary Tulathromycin
Tulathromycin is used in drugs marketed by 10 different companies: Bimeda Animal Health Ltd, Virbac Ah Inc, Elanco Us Inc, Norbrook Laboratories Ltd, Parnell Technologies Pty Ltd, Hikma Pharmaceuticals Usa Inc, Intervet Inc, Cronus Pharma Specialities India Private Ltd, Zoetis Inc, Ceva Sante Animale.
Other drugs containing Tulathromycin are: Draxxin 25 injectable solution , Tulaject 100 , Respirmycin 25 , Macrosyn
Veterinary Tulathromycin Patents
Given below is the list of patents protecting Tulathromycin, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Draxxin | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin | US6936592 | 29 May, 2018 | ZOETIS INC. |
| Draxxin | US6777393 | 29 May, 2018 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6936592 | 29 May, 2018 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6777393 | 29 May, 2018 | ZOETIS INC. |
Tulathromycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List